Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases.
Goletti D, Navarra A, Petruccioli E, Cimaglia C, Compagno M, Cuzzi G, De Carli G, Fondaco L, Franzetti F, Giannetti A, Gori A, Lapadula G, Lichtner M, Mastroianni CM, Mazzotta V, Orchi N, Pavone P, Piacentini D, Pirriatore V, Pontali E, Sarmati L, Spolti A, Tacconelli E, Galli M, Antinori A, Calcagno A, Girardi E. Goletti D, et al. Among authors: piacentini d. Int J Infect Dis. 2020 Mar;92:62-68. doi: 10.1016/j.ijid.2019.12.031. Epub 2019 Dec 27. Int J Infect Dis. 2020. PMID: 31887456 Free article.
Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean.
Odolini S, Gobbi F, Zammarchi L, Migliore S, Mencarini P, Vecchia M, di Lauria N, Schivazappa S, Sabatini T, Chianura L, Vanino E, Piacentini D, Zanotti P, Bussi A, Bartoloni A, Bisoffi Z, Castelli F. Odolini S, et al. Among authors: piacentini d. Int J Infect Dis. 2017 Sep;62:77-80. doi: 10.1016/j.ijid.2017.07.018. Epub 2017 Jul 26. Int J Infect Dis. 2017. PMID: 28756023 Free article.
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir.
Lanzafame M, Nicole S, Rizzardo S, Piacentini D, Chiesi S, Lattuada E, Diani E, Carelli M, Vento S, Gibellini D. Lanzafame M, et al. Among authors: piacentini d. New Microbiol. 2018 Oct;41(4):262-267. Epub 2018 Oct 12. New Microbiol. 2018. PMID: 30311623 Free article. Clinical Trial.
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection.
Lanzafame M, Lattuada E, Gottardo R, Piacentini D, Be G, Razzaboni E, Cattaneo P, Luise D, Vento S. Lanzafame M, et al. Among authors: piacentini d. Int J Antimicrob Agents. 2021 Mar;57(3):106290. doi: 10.1016/j.ijantimicag.2021.106290. Epub 2021 Jan 26. Int J Antimicrob Agents. 2021. PMID: 33513407 No abstract available.
41 results